HAPLN3 and prostate carcinoma: Namely, the gene encoding HAPLN3 (hyaluronan and proteoglycan link protein 3) ECM proteoglycan was found to be a part of the three-gene DNA methylation biomarker with diagnostic [477,478,479] and prognostic [480] potential in prostate cancer.